Annual Accounts Payable
$1.34 M
+$398.50 K+42.24%
December 31, 2023
Summary
- As of February 24, 2025, POAI annual accounts payable is $1.34 million, with the most recent change of +$398.50 thousand (+42.24%) on December 31, 2023.
- During the last 3 years, POAI annual accounts payable has fallen by -$30.10 thousand (-2.19%).
- POAI annual accounts payable is now -57.47% below its all-time high of $3.16 million, reached on December 31, 2019.
Performance
POAI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.14 M
-$421.10 K-26.94%
September 30, 2024
Summary
- As of February 24, 2025, POAI quarterly accounts payable is $1.14 million, with the most recent change of -$421.10 thousand (-26.94%) on September 30, 2024.
- Over the past year, POAI quarterly accounts payable has stayed the same.
- POAI quarterly accounts payable is now -69.65% below its all-time high of $3.76 million, reached on September 30, 2019.
Performance
POAI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
POAI Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +42.2% | 0.0% |
| 3 y3 years | -2.2% | +12.7% |
| 5 y5 years | +201.1% | +12.7% |
POAI Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.2% | -34.0% | +24.5% |
| 5 y | 5-year | -57.5% | +42.2% | -63.8% | +24.5% |
| alltime | all time | -57.5% | +855.2% | -69.7% | +1889.4% |
Predictive Oncology Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.14 M(-26.9%) |
| Jun 2024 | - | $1.56 M(-9.6%) |
| Mar 2024 | - | $1.73 M(+28.8%) |
| Dec 2023 | $1.34 M(+42.2%) | $1.34 M(+14.9%) |
| Sep 2023 | - | $1.17 M(+15.3%) |
| Jun 2023 | - | $1.01 M(-28.9%) |
| Mar 2023 | - | $1.42 M(+51.0%) |
| Dec 2022 | $943.50 K(-7.7%) | $943.50 K(+2.9%) |
| Sep 2022 | - | $917.30 K(-6.8%) |
| Jun 2022 | - | $983.70 K(-11.1%) |
| Mar 2022 | - | $1.11 M(+8.3%) |
| Dec 2021 | $1.02 M(-25.5%) | $1.02 M(-0.7%) |
| Sep 2021 | - | $1.03 M(+9.3%) |
| Jun 2021 | - | $942.00 K(-8.3%) |
| Mar 2021 | - | $1.03 M(-25.2%) |
| Dec 2020 | $1.37 M(-56.5%) | $1.37 M(-15.8%) |
| Sep 2020 | - | $1.63 M(-33.5%) |
| Jun 2020 | - | $2.45 M(-21.7%) |
| Mar 2020 | - | $3.13 M(-0.9%) |
| Dec 2019 | $3.16 M(+608.0%) | $3.16 M(-16.1%) |
| Sep 2019 | - | $3.76 M(+6.3%) |
| Jun 2019 | - | $3.54 M(+718.8%) |
| Mar 2019 | - | $432.20 K(-3.0%) |
| Dec 2018 | $445.70 K(+217.2%) | $445.70 K(+8.9%) |
| Sep 2018 | - | $409.10 K(+147.0%) |
| Jun 2018 | - | $165.60 K(-11.1%) |
| Mar 2018 | - | $186.30 K(+32.6%) |
| Dec 2017 | $140.50 K(-36.2%) | $140.50 K(+88.3%) |
| Sep 2017 | - | $74.60 K(+30.0%) |
| Jun 2017 | - | $57.40 K(-27.6%) |
| Mar 2017 | - | $79.30 K(-64.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $220.10 K(-66.2%) | $220.10 K(-66.0%) |
| Sep 2016 | - | $648.10 K(-13.6%) |
| Jun 2016 | - | $750.50 K(-5.2%) |
| Mar 2016 | - | $791.70 K(+21.7%) |
| Dec 2015 | $650.40 K(-70.4%) | $650.40 K(-42.9%) |
| Sep 2015 | - | $1.14 M(-54.0%) |
| Jun 2015 | - | $2.47 M(+0.4%) |
| Mar 2015 | - | $2.46 M(+12.3%) |
| Dec 2014 | $2.19 M(+106.6%) | $2.19 M(+39.1%) |
| Sep 2014 | - | $1.58 M(-2.9%) |
| Jun 2014 | - | $1.63 M(+47.4%) |
| Mar 2014 | - | $1.10 M(+3.8%) |
| Dec 2013 | $1.06 M(+44.8%) | $1.06 M(+67.0%) |
| Sep 2013 | - | $636.10 K(-3.8%) |
| Jun 2013 | - | $661.10 K(+8.0%) |
| Mar 2013 | - | $612.20 K(-16.5%) |
| Dec 2012 | $733.60 K(+0.3%) | $733.60 K(+1.4%) |
| Sep 2012 | - | $723.40 K(+9.0%) |
| Jun 2012 | - | $663.50 K(-8.9%) |
| Mar 2012 | - | $728.30 K(-0.4%) |
| Dec 2011 | $731.10 K(-4.9%) | $731.10 K(+1.5%) |
| Sep 2011 | - | $720.00 K(-1.6%) |
| Jun 2011 | - | $731.90 K(+12.1%) |
| Mar 2011 | - | $653.10 K(-15.0%) |
| Dec 2010 | $768.70 K(-5.6%) | $768.70 K(-31.9%) |
| Sep 2010 | - | $1.13 M(+9.1%) |
| Jun 2010 | - | $1.03 M(+27.9%) |
| Mar 2010 | - | $808.80 K(-0.7%) |
| Dec 2009 | $814.10 K(+63.8%) | $814.10 K(+18.7%) |
| Sep 2009 | - | $686.10 K(+38.0%) |
| Dec 2008 | $497.10 K | $497.10 K |
FAQ
- What is Predictive Oncology annual accounts payable?
- What is the all time high annual accounts payable for Predictive Oncology?
- What is Predictive Oncology annual accounts payable year-on-year change?
- What is Predictive Oncology quarterly accounts payable?
- What is the all time high quarterly accounts payable for Predictive Oncology?
- What is Predictive Oncology quarterly accounts payable year-on-year change?
What is Predictive Oncology annual accounts payable?
The current annual accounts payable of POAI is $1.34 M
What is the all time high annual accounts payable for Predictive Oncology?
Predictive Oncology all-time high annual accounts payable is $3.16 M
What is Predictive Oncology annual accounts payable year-on-year change?
Over the past year, POAI annual accounts payable has changed by +$398.50 K (+42.24%)
What is Predictive Oncology quarterly accounts payable?
The current quarterly accounts payable of POAI is $1.14 M
What is the all time high quarterly accounts payable for Predictive Oncology?
Predictive Oncology all-time high quarterly accounts payable is $3.76 M
What is Predictive Oncology quarterly accounts payable year-on-year change?
Over the past year, POAI quarterly accounts payable has changed by $0.00 (0.00%)